Home > Back to Publisher > Report Information

Cardiac Rhythm Management Devices: World Market Outlook 2011-2021

Visiongain
December 7, 2011
145 Pages - SKU: VSG6777449

Abstract Table of Contents Related Reports

Cardiac Rhythm Management Devices: World Market Outlook 2011-2021

How will the cardiac rhythm management devices market perform from 2011? Our new report shows you potential sales and trends to 2021, discussing opportunities and prospects.

Discover sales for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation market at segment and national levels. Our report gives you business research, analysis and data.

See sales predictions and discussions for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation. Discover opportunities in these markets. Find data you need in our report.

Discover the activities shaping the development of cardiac rhythm management devices market. Through our research and analysis we aim to save you time and help in your decisions.

The market will change with the launch of new products such as devices suitable for use with MRI and biological pacemakers. Find R&D trends and commercial opportunities there.

Assess companies such as Medtronic, Boston Scientific and St. Jude Medical.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Detailed analysis of the global Cardiac Rhythm Management Devices Market

Cardiac Rhythm Management Devices: World Market Outlook 2011-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses, opinions from our survey and a review of companies. Discover over 100 tables and charts and two research interviews (shown in the accompanying lists).

Why you should buy Cardiac Rhythm Management Devices: World Market Outlook 2011-2021

In this report, you will receive the following benefits in particular:

You will receive our assessment of the current market for cardiac rhythm management devices, with respect to the leading segments, products, companies and national markets
You will discover sales trends for the overall cardiac rhythm management devices market from 2011 to 2021 - seeing where commercial growth will occur
You will discover sales trends for the main segments - implantable cardioverter defibrillator, pacemaker, cardiac resynchronisation therapy and cardiac ablation - from 2011 to 2021, with detailed discussions of market potential
You will receive sales forecasts for leading geographical markets (US, Japan, Germany, France, Italy, Spain, UK, China and India), with informed discussion
You will assess leading manufacturers in the cardiac rhythm management devices market
You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the cardiac rhythm management devices market from 2011 onwards
You will be able to investigate competition and opportunities influencing the cardiac rhythm management devices market from 2011 onwards
You will see what will stimulate and restrain the market from 2011
You will discover the unmet needs in the market, driving the growth from 2011 onwards
You will view expert opinion from our survey, including full interview transcripts.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report

Additional Information

Report Excerpt

6. The Cardiac Resynchronisation Therapy Devices (CRT) Market, 2010-2021

6.1 Chapter Overview

In this chapter we discuss in detail the CRT market including analysis of leading products in the market. This chapter includes our forecasts for growth of the CRT market, based on our analyses of the currently available and pipeline products.

Companies Listed

3M pharmaceuticals
Abbott Laboratories
Ablation Frontiers
ARCO
Astra Zeneca
AtriCure
ATS Medical
Aventis
Biosense Webster
BioTronik
Boston Scientific
Bristol-Myers Squibb
C.R Bard
C.R Bard Electrophysiology
Cameron Health
CardioFocus
Center for Devices and Radiological Health (CDRH)
CryoCath Technologies
CryoCor
Endosense
European Heart Rhythm Association (EHRA)
FDA's MedWatch
Food and Drug Administration (FDA)
Global Harmonization Task Force
Guidant Corporation
Hansen Medical
Impulse Dynamics
InnerPulse
Japanese Ministry of Health, Labour and Welfare (MHLW)
John Hopkins University Medical School
Johnson & Johnson
Karolinska Institute
MedicalCV
Medico
MediVed
Medtronic
MHRA (Medicines and Healthcare Products Regulatory Agency)
New York Heart Association
Odem Medical
Pfizer
ProRhythm
Rainbow Medical
Shree Pacetronix
Siemens Healthcare
Sinai Hospital, Baltimore
Sorin Group
St. Jude Medical
Stony Brook University
Transurgical
UC Davis
University of Bologna
University of Missouri
US Bankruptcy Court for the District of Delaware
World Society of Arrhythmias
Wyeth
Zoll Medical Corporation

1. Executive Summary: 1.1 Cardiac Rhythm Management Devices Market Highlights; 1.2 Overview of Chapter Content; 1.3 Research and Analysis Methods; 1.4 Glossary of Terms Relating to Cardiac Rhythm Management Devices
2. Introduction: 2.1 Cardiac Rhythm Management Definition; 2.2 The Heart; 2.3 Cardiac Rhythm Disorders; 2.4 Cardiac Rhythm Management Devices; 2.5 Regulation of Cardiac Rhythm Management Devices
3. The Global Cardiac Rhythm Management Devices Market, 2010-2021: 3.1 Cardiac Rhythm Management Devices: Market Overview; 3.2 Regional Market Breakdown, 2010; 3.3 Global Cardiac Rhythm Management Devices Market Forecast, 2011-2015; 3.4 Global Cardiac Rhythm Management Devices Market Forecast, 2015-2021; 3.5 Leading Regional Markets for Cardiac Rhythm Management Devices, 2011-2021
4. The Implantable Cardioverter Defibrillator (ICD) Market, 2010-2021: 4.1 Chapter Overview; 4.2 Leading Companies in the Defibrillator Market, 2010; 4.3 The ICD Market in 2010; 4.4 The ICD Market Forecast, 2011-2021; 4.5 The ICD Market Pipeline; 4.6 SWOT Analysis of the ICD Market, 2011-2021
5. The Pacemaker Market, 2010-2021: 5.1 Chapter Overview; 5.2 Medtronic Dominates the Pacing Devices Market; 5.3 The Pacemaker Market in 2010; 5.4 The Pacemaker Market Forecast, 2011-2021; 5.5 The Pacemaker Market Segments, 2010-2021; 5.6 The Pacemaker Pipeline; 5.7 SWOT Analysis of the Pacemaker Market, 2011-2021
6. The Cardiac Resynchronisation Therapy Devices (CRT) Market, 2010-2021: 6.1 Chapter Overview; 6.2 The Cardiac Resynchronisation Therapy Market in 2010; 6.3 Cardiac Resynchronisation Therapy Market Forecast, 2011-2021; 6.4 Cardiac Resynchronisation Therapy Pipeline, 2011; 6.5 SWOT Analysis of the Cardiac Resynchronisation Therapy Market, 2011-2021
7. The Cardiac Ablation Devices Market, 2010-2021: 7.1 Chapter Overview; 7.2 The Cardiac Ablation Devices Market in 2010; 7.3 Cardiac Ablation Market Forecast, 2011-2021; 7.4 The Cardiac Ablation Pipeline; 7.5 SWOT Analysis of the Cardiac Ablation Market
8. Leading Companies in the Cardiac Rhythm Management Market, 2010: 8.1 Boston Scientific; 8.2 Medtronic; 8.3 St. Jude Medical; 8.4 Other Companies in the Cardiac Rhythm Management Market
9. Expert Opinions: 9.1 Dr. Gideon Meiry, Former CTO, Odem Medical; 9.2 Dr. Mauro Biffi, Senior Electrophysiologist, University of Bologna
10. Conclusions: 10.1 The Cardiac Rhythm Management Devices Market, 2010-2021; 10.2 The Implantable Cardioverter Defibrillator Market, 2010-2021; 10.3 The Pacemaker Market, 2010-2021; 10.4 The Cardiac Resynchronisation Therapy Market, 2010-2021; 10.5 The Cardiac Ablation Devices Market, 2010-2021
Appendix A
Appendix B
Visiongain report evaluation form
List of Tables: Table 2.1 The Cardiology Device Market ($bn) by Segment, 2010; Table 2.2 New York Heart Association Functional Classification System; Table 2.3 Common Methods Used to Diagnose CHF; Table 2.4 Management Options for Patients with Heart Failure; Table 2.5 Risk Factors for Developing Arrhythmias; Table 2.6 Treatment Options for Patient Suffering From Arrhythmias; Table 2.7 The Advantages and Disadvantages of Cardiac Resynchronisation Therapy (CRT); Table 3.1 The Cardiac Rhythm Management Devices Market ($bn) by Segment, 2010; Table 3.2 Leading National Markets for Cardiac Rhythm Management Devices ($bn), 2010; Table 3.3 The Global Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2021; Table 3.4 Leading Cardiac Rhythm Management Devices Regional Market Forecasts ($bn), 2010-2015; Table 3.5 Leading Cardiac Rhythm Management Devices Regional Market Forecasts ($bn), 2015-2021; Table 3.6 Chinese Cardiac Rhythm Management Devices Market: Drivers and Restraints, 2011-2021; Table 4.1 Leading Companies in the Defibrillator Market by Sales ($bn), 2010; Table 4.2 The ICD Market ($bn) by Region/ Country, 2010; Table 4.3 Leading Products in the ICD Market, 2010; Table 4.4 The ICD Market Forecast ($bn), 2010-2015; Table 4.5 The ICD Market Forecast ($bn), 2015-2021; Table 4.6 The ICD Development Pipeline, 2011; Table 4.7 SWOT Analysis of the ICD Market, 2011-2021; Table 5.1 Leading Companies in the Pacing Devices Market by Sales ($bn) and Market Share (%), 2010; Table 5.2 The Pacemaker Market ($bn) by Segment, 2010; Table 5.3 The Pacemaker Market ($bn) by Region/ Country, 2010; Table 5.4 Leading Products in the Pacemaker Market, 2010; Table 5.5 The Pacemaker Market Forecast ($bn), 2010-2021; Table 5.6 The Dual-Chamber Pacemaker Market Forecast ($bn), 2010-2015; Table 5.7 The Dual-Chamber Pacemaker Market Forecast ($bn), 2015-2021; Table 5.8 The Single Chamber Pacemaker Market Forecast ($bn), 2010-2021; Table 5.9 The External Pacemaker Market Forecast ($bn), 2010-2021; Table 5.10 Pacemaker Development Pipeline, 2011; Table 5.11 SWOT Analysis of the Pacemaker Market, 2011-2021; Table 6.1 The Cardiac Resynchronisation Therapy Market ($bn) by Segment, 2010; Table 6.2 Leading Products in the Cardiac Resynchronisation Market, 2010; Table 6.3 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2010-2015; Table 6.4 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2015-2021; Table 6.5 Cardiac Resynchronisation Development Pipeline, 2011; Table 6.6 SWOT Analysis of the Cardiac Resynchronisation Therapy Market, 2011-2021; Table 7.1 The Cardiac Ablation Market ($m) by Region/Country, 2010; Table 7.2 The Leading Products in the Cardiac Ablation Market, 2010; Table 7.3 The Cardiac Ablation Market Forecast ($m), 2010-2015; Table 7.4 The Cardiac Ablation Market Forecast ($m), 2015-2021; Table 7.5 The Cardiac Ablation Pipeline, 2011; Table 7.6 SWOT Analysis of The Cardiac Ablation Market, 2011-2021; Table 8.1 Boston Scientific Sales ($bn) by Business Segment, 2010; Table 8.2 Boston Scientific CRM Segment Sales ($m), 2009 and 2010; Table 8.3 Boston Scientific Rankings by Sales, 2010; Table 8.4 Medtronic Sales ($m) by Business Segment, 2009 and 2010; Table 8.5 Medtronic CRDM Sales ($m), 2010; Table 8.6 Medtronic Sales ($bn) by Region, 2010; Table 8.7 Medtronic Rankings by Sales, 2010; Table 8.8 St. Jude Medical Sales ($m) by Business Segment, 2010; Table 8.9 St. Jude Medical CRM Segment Sales ($m), 2010; Table 8.10 St. Jude Medical Rankings by Sales, 2010; Table 8.11 Other Companies in the Cardiac Rhythm Management Market, 2011
List of Figures: Figure 2.1 Market Shares (%) of the Leading Segments in the Cardiology Device Market, 2010; Figure 2.2 Sales ($bn) of Leading Segments in the Cardiology Device Market, 2010; Figure 2.3 The Exterior of The Human Heart; Figure 2.4 The Interior of The Human Heart; Figure 2.5 The Conducting System of The Human Heart; Figure 2.6 The Timeline of Important Developments in the History of Pacemakers; Figure 3.1 The Cardiac Rhythm Management Devices Market Share (%) by Segment, 2010; Figure 3.2 The Cardiac Rhythm Management Devices Market ($bn) by Segment, 2010; Figure 3.3 Leading National Market Shares (%) in the Cardiac Rhythm Management Devices Market, 2010; Figure 3.4 Leading National Markets ($bn) in the Cardiac Rhythm Management Devices Market, 2010; Figure 3.5 The Global Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2021; Figure 3.6 The US Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015; Figure 3.7 The European Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015; Figure 3.8 The Asian Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015; Figure 3.9 The US Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021; Figure 3.10 The European Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021; Figure 3.11 The Asian Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021; Figure 4.1 Market Share (%) of Leading Companies in the Defibrillator Market, 2010; Figure 4.2 Sales ($bn) of Leading Companies in the Defibrillator Market, 2010; Figure 4.3 The ICD Market Share (%) by Region/Country, 2010; Figure 4.4 The ICD Market ($bn) by Region/Country, 2010; Figure 4.5 The ICD Market Forecast ($bn), 2010-2015; Figure 4.6 The ICD Market Forecast ($bn), 2015-2021; Figure 4.7 The Remote Monitoring Network for ICD Devices; Figure 5.1 Market Share (%) of Leading Companies in the Pacing Devices Market, 2010; Figure 5.2 Market Share (%) of Leading Segments in the Pacemaker Market, 2010; Figure 5.3 The Pacemaker Market ($bn) by Segment, 2010; Figure 5.4 The Pacemaker Market Share (%) by Region/Country, 2010; Figure 5.5 The Pacemaker Market ($bn) by Region/Country, 2010; Figure 5.6 The Pacemaker Market Forecast ($bn), 2010-2021; Figure 5.7 The Dual-Chamber Pacemaker Market Forecast ($bn), 2010-2015; Figure 5.8 The Dual-Chamber Pacemaker Market Forecast ($bn), 2015-2021; Figure 5.9 The Single Chamber Pacemaker Market Forecast ($bn), 2010-2021; Figure 5.10 The External Pacemaker Market Forecast ($bn), 2010-2021; Figure 6.1 Market Share (%) of Leading Segments in the Cardiac Resynchronisation Therapy Market, 2010; Figure 6.2 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2010-2015; Figure 6.3 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2015-2021; Figure 7.1 The Cardiac Ablation Market Share (%) by Region/Country, 2010; Figure 7.2 The Cardiac Ablation Market ($m) by Region/Country, 2010; Figure 7.3 The Cardiac Ablation Market Forecast ($m), 2010-2015; Figure 7.4 The Cardiac Ablation Market Forecast ($m), 2015-2021; Figure 8.1 Boston Scientific Sales Share (%) by Business Segment, 2010; Figure 8.2 Boston Scientific Sales ($bn) by Business Segment, 2010; Figure 8.3 Boston Scientific CRM Segment Sales ($m), 2009 and 2010; Figure 8.4 Boston Scientific CRM Segment US Sales ($m), 2009 and 2010; Figure 8.5 Boston Scientific CRM Segment International Sales ($m), 2009 and 2010; Figure 8.6 Medtronic Sales ($m) by Business Segment, 2009 and 2010; Figure 8.7 Medtronic Sales Share (%) by Business Segment, 2010; Figure 8.8 Medtronic CRDM Sales Share (%) 2010 by Segment, 2010; Figure 8.9 Medtronic Sales Share (%) by Region, 2010; Figure 8.10 St. Jude Medical Sales Share (%) by Business Segment, 2010; Figure 8.11 St. Jude Medical Sales Share (%) by Business Segment, 2010; Figure 8.12 St. Jude Medical CRM Segment Sales Share (%), 2010

Cardiac Rhythm Management Devices: World Market Outlook 2011-2021

Share this report

Other tasks

Research Assistance

Related Markets

Cardiovascular Devices Reports

Free Alert Me service